Literature DB >> 30796490

Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

J A Kanis1,2, C Cooper3,4, R Rizzoli5, J-Y Reginster6,7.   

Abstract

A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. in Osteoporos Int https://doi.org/10.1007/s00198-018-4704-5 , 2018). This manuscript updates the previous guidelines document, published in 2013 (Kanis et al. in Osteoporos Int 24:23-57, 2013) and is written in a European perspective. The present article reports and summarizes the main recommendations included in this 2018 guidance document.

Entities:  

Keywords:  Bone mineral density; Diagnosis of osteoporosis; FRAX; Fracture risk assessment; Health economics; Treatment of osteoporosis

Mesh:

Year:  2019        PMID: 30796490      PMCID: PMC6422308          DOI: 10.1007/s00223-018-00512-x

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  2 in total

1.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-10-15       Impact factor: 4.507

2.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

  2 in total
  21 in total

1.  Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.

Authors:  A Lanyan; P Marques-Vidal; E Gonzalez-Rodriguez; D Hans; O Lamy
Journal:  Osteoporos Int       Date:  2019-12-17       Impact factor: 4.507

2.  Effect of Rhizoma Drynariae on differential gene expression in ovariectomized rats with osteoporosis based on transcriptome sequencing.

Authors:  Hui Su; Haipeng Xue; Shang Gao; Binghan Yan; Ruochong Wang; Guoqing Tan; Zhanwang Xu; Lingfeng Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-02       Impact factor: 6.055

Review 3.  A Review of CT-Based Fracture Risk Assessment with Finite Element Modeling and Machine Learning.

Authors:  Ingmar Fleps; Elise F Morgan
Journal:  Curr Osteoporos Rep       Date:  2022-09-01       Impact factor: 5.163

4.  Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.

Authors:  Xiao-Ke Kong; Zhi-Yun Zhao; Deng Zhang; Rui Xie; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Wei-Qing Wang; Jian-Min Liu; Bei Tao
Journal:  Osteoporos Int       Date:  2022-05-18       Impact factor: 5.071

5.  Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy.

Authors:  Wei Wang; Li-Mei Zhang; Chang Guo; Jian-Feng Han
Journal:  Nutr Metab (Lond)       Date:  2020-04-16       Impact factor: 4.169

6.  Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

Authors:  J A Kanis; N C Harvey; E McCloskey; O Bruyère; N Veronese; M Lorentzon; C Cooper; R Rizzoli; G Adib; N Al-Daghri; C Campusano; M Chandran; B Dawson-Hughes; K Javaid; F Jiwa; H Johansson; J K Lee; E Liu; D Messina; O Mkinsi; D Pinto; D Prieto-Alhambra; K Saag; W Xia; L Zakraoui; J -Y Reginster
Journal:  Osteoporos Int       Date:  2019-11-13       Impact factor: 4.507

Review 7.  Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management.

Authors:  Anett Vincze; János Gaál; Zoltán Griger
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

8.  Bilateral Acute Osteoporotic Lumbar Pedicle Fracture Presenting with Associated Neurological Deficit: A Case Report and Review of Literature.

Authors:  James Ebot; Angela M Bohnen; Kingsley Abode-Iyamah
Journal:  Cureus       Date:  2020-03-14

9.  Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions.

Authors:  Josep Blanch-Rubió; Natalia Soldevila-Domenech; Laura Tío; Jone Llorente-Onaindia; Manuel Ciria-Recasens; Luciano Polino; Alba Gurt; Rafael de la Torre; Rafael Maldonado; Jordi Monfort; The Covidmar Study Group
Journal:  Aging (Albany NY)       Date:  2020-10-20       Impact factor: 5.682

10.  An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis.

Authors:  Nannan Li; Dennis Cornelissen; Stuart Silverman; Daniel Pinto; Lei Si; Ingrid Kremer; Sandrine Bours; Robin de Bot; Annelies Boonen; Silvia Evers; Joop van den Bergh; Jean-Yves Reginster; Mickaël Hiligsmann
Journal:  Pharmacoeconomics       Date:  2020-10-07       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.